menu
    • menu

    Company profile for Propella Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Propella is committed to pioneering innovative therapeutics while minimizing development risks. Our approach integrates established scientific principles, novel methodologies, and insightful development strategies to create products that are smarter, safer, and more efficacious. As a privately owned developmental-stage firm, we are devoted to introducing top-tier drugs to market, leveraging active ingredients with well-underst...
    Propella is committed to pioneering innovative therapeutics while minimizing development risks. Our approach integrates established scientific principles, novel methodologies, and insightful development strategies to create products that are smarter, safer, and more efficacious. As a privately owned developmental-stage firm, we are devoted to introducing top-tier drugs to market, leveraging active ingredients with well-understood mechanisms of action. Currently, our primary focus is on PRL-02, our lead product candidate, which is undergoing a phase 1 dose-escalation study targeting metastatic prostate cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Propella TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Suite 120-3 Pittsboro, NC 27312
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://propellatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/propella-therapeutics-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Outcome Capital Announces Acquisition of Propella Therapeutics
    Outcome Capital Announces Acquisition of Propella Therapeutics

    04 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240104140935/en

    BUSINESSWIRE
    04 Jan 2024
    Share Share
    Astellas completes acquisition of Propella Therapeutics
    Astellas completes acquisition of Propella Therapeutics

    26 Dec 2023

    // INDIAN PHARMA POST

    https://www.indianpharmapost.com/news/astellas-completes-acquisition-of-propella-therapeutics-15067

    INDIAN PHARMA POST
    26 Dec 2023
    Share Share
    Astellas to Acquire Propella Therapeutics
    Astellas to Acquire Propella Therapeutics

    15 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/astellas-to-acquire-propella-therapeutics-301989842.html

    PR NEWSWIRE
    15 Nov 2023
    Share Share
    Propella Announces Presentation of Ph1/2a Data of PRL-02 for Prostate Cancer
    Propella Announces Presentation of Ph1/2a Data of PRL-02 for Prostate Cancer

    14 Feb 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/02/14/2607588/0/en/Propella-Therapeutics-Announces-Presentation-of-Updated-Phase-1-2a-Data-of-PRL-02-for-the-Treatment-of-Advanced-Prostate-Cancer-at-2023-ASCO-Genitourinary-GU-Cancers-Symposium.html

    GLOBENEWSWIRE
    14 Feb 2023
    Share Share
    Propella Therapeutics Announces Presentation of Phase 1/2 Data of PRL-02
    Propella Therapeutics Announces Presentation of Phase 1/2 Data of PRL-02

    08 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/08/2512425/0/en/Propella-Therapeutics-Announces-Presentation-of-Phase-1-2-Data-of-PRL-02-for-the-Treatment-of-Advanced-Prostate-Cancer-at-ESMO-Congress-2022.html

    GLOBENEWSWIRE
    08 Sep 2022
    Share Share
    Propella Tx Signs Licensing Agreement with Jiangsu Aosaikang Pharmaceutical
    Propella Tx Signs Licensing Agreement with Jiangsu Aosaikang Pharmaceutical

    07 Apr 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/04/07/2418425/0/en/Propella-Therapeutics-Announces-Licensing-Agreement-with-Jiangsu-Aosaikang-Pharmaceutical-Co-Ltd-ASK-Pharm-for-Development-and-Commercial-Rights-to-CGS-200-5-in-Greater-China.html

    GLOBENEWSWIRE
    07 Apr 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search